Muscle syndrome with clofibrate usage
Kra, S.J.
Connecticut Medicine 38(7): 348-349
1974
ISSN/ISBN: 0010-6178 PMID: 4845133 Document Number: 82154
Document emailed within 1 workday
Related Documents
Bojs, G.; Fahlén, M.; Lapidus, L. 1979: Clofibrate-induced muscle problems Lakartidningen 76(30-31): 2631-2632Mertz, D.P. 1980: Clofibrate therapy in hypercholesterolemia. Reports on medium-long-term movements of HDL- cholesterol by the action of clofibrate Fortschritte der Medizin 98(45): 1761-1766
Gutíerrez Millet, V.; Gómez Tejada, E.; Bello Nicolau, I.; Barrientos Guzman, A.; Ruilope Urioste, L.M.; Rodicio Diaz, J.L. 1976: Acute myopathic syndrome induced by clofibrate in periodic dialysis Revista Clinica Espanola 141(1): 85-89
Fabre, J.; Denizot, M.; Wildi, E.; Micheli, H.; Berthoud, S. 1973: Hypolipemic property and myotoxic action of clofibrate in a case of nephrotic syndrome Schweizerische Rundschau für Medizin Praxis 62(23): 732-737
Goulston, K. 1972: Drug usage in the irritable colon syndrome Medical Journal of Australia 1(22): 1126-1131
Fredriksen, C.; Johannessen, A.C.; Jonsson, R. 1995: T-cell receptor V-gene usage in Sjögren's syndrome Advances in Experimental Medicine and Biology 371b: 1203-1206
Akbaş, T.ür.; Imeryüz, N.şe.; Bayalan, F.; Baltacioğlu, F.; Atagündüz, P.; Mülazimoğlu, L.üt.; Direskeneli, H. 2007: A case of Budd-Chiari syndrome with Behcet's disease and oral contraceptive usage Rheumatology International 28(1): 83-86
Marshall, A.J.; Wu, G.E.; Paige, G.J. 1996: Frequency of VH81x usage during B cell development: initial decline in usage is independent of Ig heavy chain cell surface expression Journal of Immunology 156(6): 2077-2084
Ryu, J.Y.; Watson, H.K. 1987: SSMB syndrome. Symptomatic supernumerary muscle belly syndrome Clinical Orthopaedics and Related Research 216: 195-202
Schwartzkopff, W. 1979: Clofibrate banned - what now? Münchener Medizinische Wochenschrift 121(15): 529-533
Macela, A. 1970: Clofibrate Spofa Casopis Lekaru Ceskych 109(30): 700-701
Elert, J.; Dahlqvist, S.R.; Almay, B.; Eisemann, M. 1993: Muscle endurance, muscle tension and personality traits in patients with muscle or joint pain--a pilot study Journal of Rheumatology 20(9): 1550-1556
Gatton, M.L.; Pearcy, M.J.; Pettet, G.J. 1999: Difficulties in estimating muscle forces from muscle cross-sectional area. An example using the psoas major muscle Spine 24(14): 1487-1493
Louthrenoo, W.; Weerayutwattana, N.; Lertprasertsuke, N.; Sukitawut, W. 2002: Serum muscle enzymes, muscle pathology and clinical muscle weakness: correlation in Thai patients with polymyositis/dermatomyositis Journal of the Medical Association of Thailand 85(1): 26-32
Baïsset, A.; Cotonat, J.; Dumas, J.C.; Montastruc, P. 1973: Antidiuretic action of clofibrate Therapie 28(4): 651-661
Kuś, W.M.; Rapała, K. 1978: Gracilis muscle syndrome Wiadomosci Lekarskie 31(13): 937-940
Jung, W.; Kremer, G.J.; Müller, D. 1975: Clofibrate treatment of diabetics with hyperproteinemias Münchener Medizinische Wochenschrift 117(44): 1783-1786
Holzgreve, H. 1979: Clofibrate prohibition: a wrong decision? Münchener Medizinische Wochenschrift 121(2): 43-44
Burvald, S. 1979: Acute muscle compartment syndrome Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 99(30): 1522-1526
Marković, B.D.; Prica, V.S.; Bozanić, K.S.; Colović, V.C.; Mandić, R.M. 1982: Significance of the lumboiliopsoas muscle syndrome Srpski Arhiv Za Celokupno Lekarstvo 110(7-8): 871-878